Chapters

Transcript

Video

In China, how does FoundationONE NGS sequencing compare to common "hotspot panels" with respect to detecting clinically actionable alterations?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Yilong Wu, MD

Yilong Wu, MD

Vice President
Guangdong General Hospital
Guangdong Academy of Medical Sciences
Director, Guangdong Lung Cancer Institute
Guangzhou, China